Syntax Research, Inc. Medtronic PLC Transaction History
Syntax Research, Inc.
- $131 Billion
- Q1 2024
A detailed history of Syntax Research, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Syntax Research, Inc. holds 6,033 shares of MDT stock, worth $466,773. This represents 0.4% of its overall portfolio holdings.
Number of Shares
6,033
Previous 5,814
3.77%
Holding current value
$466,773
Previous $479 Million
9.77%
% of portfolio
0.4%
Previous 0.4%
Shares
3 transactions
Others Institutions Holding MDT
# of Institutions
2,237Shares Held
1.05BCall Options Held
6.1MPut Options Held
7.84M-
Vanguard Group Inc Valley Forge, PA126MShares$9.77 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY114MShares$8.82 Billion0.23% of portfolio
-
State Street Corp Boston, MA60.1MShares$4.65 Billion0.24% of portfolio
-
Jpmorgan Chase & CO New York, NY31.6MShares$2.45 Billion0.25% of portfolio
-
Capital Research Global Investors Los Angeles, CA30.9MShares$2.39 Billion0.63% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $103B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...